Omeprazole once or twice daily with clarithromycin and metronidazole for Helicobacter pylori eradication in a Canadian community practice

Canadian Journal of Gastroenterology

Volumn 14, Issue 1, 2000, Pages 27-31

  Chiba, Naoki ^a,b   Marshall, Cheryl P ^a  

^a Surrey GI Clinic   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

Clarithromycin; Controlled clinical trial; Eradication; Helicobacter pylori; Metronidazole; Omeprazole

Indexed keywords

CLARITHROMYCIN; METRONIDAZOLE; OMEPRAZOLE;

ADULT; AGED; ARTICLE; CANADA; CLINICAL TRIAL; COHORT ANALYSIS; COMMUNITY CARE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; FLATULENCE; GASTROINTESTINAL ENDOSCOPY; GIEMSA STAIN; GRAM NEGATIVE INFECTION; HEADACHE; HELICOBACTER PYLORI; HISTOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NAUSEA; PATIENT COMPLIANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STOMACH ANTRUM; SWEATING; TASTE DISORDER;

EID: 0033960643     PISSN: 08357900     EISSN: None     Source Type: Journal    
DOI: 10.1155/2000/916417     Document Type: Article

References (21)

1. Bazzoli F, Zagari RM, Fossi S, Pozzato P, Roda A, Roda E. Efficacy and tolerability of a short term, low dose triple therapy for eradication of Helicobacter pylori. Gastroenterology 1993;104:A40. (Abst)
2. Lind T, Veldhuyzen van Zanten SJO, Unge P, et al. Eradication of Helicobacter pylori using one week triple therapies combining omeprazole with two antimicrobials - the MACH 1 study. Helicobacter 1996;1:138-44.
3. Lind T, Mégraud F, Unge P, et al. The MACH2 study: role of omeprazole in eradication of Helicobacter pylori with 1-week triple therapies. Gastroenterology 1999;116:248-53.
4. Jaup BH, Norrby A. Comparison of two low-dose one-week triple therapy regimens with and without metronidazole for cure of H pylori infection. Aliment Pharmacol Ther 1996;10:275-7.
5. Misiewicz JJ, Harris AW, Bardhan KD, et al. One week triple therapy for H pylori: a multicentre comparative study. Lansoprazole Helicobacter Study Group. Gut 1997;41:735-9.
6. Adamek RJ, Szymanski C, Pfaffenhach B. Pantoprazole vs omeprazole in one-week low-dose triple therapy for cure of H pylori infection. Gastroenterology 1997;112:A53. (Abst)
7. Chiba N, Veldhuyzen van Zanten SJO, Bradette M, Sinclair P. Canadian omeprazole triple therapy results from the MACH 1 study. Can J Gastroenterol 1998;12:90A-1A. (Abst).
8. Chiba N, Sinclair P. Metronidazole 500mg is as effective as metronidazole 400mg in the MACH 1 regimen for H pylori eradication: a meta-analysis. Can J Gastroenterol 1998;12 (Suppl A):91A. (Abst S50)
9. Current European concepts in the management of Helicobacter pylori infection. The Maastricht Consensus Report. European Helicobacter Pylori Study Group. Gut 1997;41:8-13.
10. Hunt R, Thomson ABR, Consensus Conference participants. Canadian Helicobacter pylori Consensus Conference. Can J Gastroenterol 1998;12:31-41.
11. Chiba N. Omeprazole and clarithromycin with and without metronidazole for the eradication of Helicobacter pylori. Am J Gastroenrerol 1996;91:2139-43.
12. Yousfi MM, El-Zimaity HMT, Al-Assi MT, Cole RA, Genta RM, Graham DY. Metronidazole, omeprazole and clarithromycin: an effective combination therapy for Helicobacter pylori infection. Aliment Pharmacol Ther 1995;9:209-12.
13. Weiss K, Laverdière M, Restieri C. Comparison of activity of 10 antibiotics against clinical strains of Helicobacter pylori by three different techniques. Can J Gastroenterol 1998;12:181-5.
14. Taylor DE, Jiang Q, Fedorak RN. Antibiotic susceptibilities of Helicobacter pylori strains isolated in the Province of Alberta. Can J Gastroenterol 1998;12:295-8.
15. Fallone CA, Loo V, Barkun AN, De Souza E, Lavallee J, Wickham C. Rate of Helicobacter pylori resistance to metronidazole, clarithromycin and six other agents. Can J Gastroenterol 1996;10:30A. (Abst S33)
16. Best LM, Haldane DJM, Veldhuyzen van Zanten SJO. Susceptibility of H pylori in Canada to clarithromycin and metronidazole. Gut 1996;39:A13. (Abst 1A:39).
17. Bardhan KD, Bayerdorffer E, Delchier JP, et al. H pylori (Hp) eradication with omeprazole (O), metronidazole (M) and amoxicillin (A): the impact of drug dosing & resistance on efficacy - the HOMER story. Gastroenterology 1998;114:A65. (Abst G0264)
18. Best LM, Haldane DJ, Bezanson GS, Veldhuyzen van Zanten SJO. Helicobacter pylori: primary susceptibility to clarithromycin in vitro in Nova Scotia. Can J Gastroenterol 1997;11:298-300.
19. Misiewicz JJ, Tytgat GNJ, Goodwin CS, et al. The Sydney System: A new classification of gastritis. Working party reports. World Congress of Gastroenterology, Sydney, August 26-31, 1990:1-10.
20. Navratil E, Soule JC, Rousseau M, et al. Comparison of immunohistochemistry and histology for the diagnosis of Helicobacter pylori infection after treatment. Gut 1995;37(Suppl 1):A35. (Abst 140)
21. Cohen H, Laine L. Endoscopic methods for the diagnosis of Helicobacter pylori. Aliment Pharmacol Ther 1997;11(Suppl 1):3-9.